Pediatric Restless Legs Syndrome

Journal of Child Neurology - Tập 26 Số 11 - Trang 1365-1376 - 2011
Daniel L. Picchietti1, Robert Arbuckle2, Linda Abetz2, Jeffrey S. Durmer3, Anna Ivanenko4, Judith Owens5, Jens Croenlein6, Richard P. Allen7, Arthur S. Walters8
1University of Illinois School of Medicine and Carle Foundation Hospital, Urbana, Illinois
2Mapi Values Ltd, Cheshire, United Kingdom
3Georgia State University and Fusion Sleep Medicine Program, Atlanta, Georgia
4Division of Child and Adolescent Psychiatry, Children’s Memorial Hospital, Chicago, Illinois
5Ambulatory Pediatrics, Brown Medical School, Providence, Rhode Island
6Boehringer Ingelheim Pharma GmbH & Co. KG, Clinical Research CNS, Biberach, Germany
7Department of Neurology, Johns Hopkins University, Baltimore, Maryland
8Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee

Tóm tắt

The specific aims of this study were to collect and analyze detailed symptom descriptions from patients with pediatric restless legs syndrome, ages 6 to 17 years, as well as assess symptom impact and the usefulness of drawings. Trained qualitative interviewers conducted face-to-face audio-recorded interviews of children and adolescents who met criteria for definite restless legs syndrome. Thirty-three patients in 3 age groups used 16 different categories of descriptors for restless legs sensations, with a mean of 3 or more categories used per patient in each age group. “Need to move/kick,” “pain/hurts,” “uncomfortable/cannot get comfortable,” and “like bugs or ants/crawling” were the most common descriptors. Two-thirds reported daytime sensations, and nearly half had arm involvement. They described impact on sleep, cognitive function, and affect. Drawings provided useful diagnostic information. These detailed empirical data will be useful in clinical practice, as well as in the development of formal diagnostic tools and severity measures.

Từ khóa


Tài liệu tham khảo

10.1016/j.smrv.2008.12.002

10.1016/j.sleep.2009.11.014

10.1007/s00415-009-0134-9

10.1542/peds.2006-2767

10.1111/j.1469-8749.2010.03796.x

10.1002/ana.20292

10.1016/j.sleep.2005.05.006

10.1001/archinte.165.11.1286

10.1093/sleep/32.6.772

10.1002/mds.22016

10.1016/j.eplepsyres.2007.05.007

10.1620/tjem.213.269

10.1093/sleep/28.11.1437

10.1056/NEJMcp021288

10.1016/S1389-9457(03)00010-8

10.1016/j.sleep.2007.08.005

10.1016/j.sleep.2007.08.012

American Psychiatric Association, 2000, Diagnostic and Statistical Manual of Mental Disorders, 4

DuPaul GJ, 1998, ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

10.1016/j.sleep.2010.03.016

10.1177/160940690600500304

10.1093/intqhc/mzm042

United States Food and Drug Administration. The Importance of Patient-Reported Outcomes… It’s All About the Patients. 2006. http://www.fda.gov/fdac/features/2006/606_patients.html. Accessed March 22, 2009.

United States Food and Drug Administration. Guidance for Industry: Patient-Reported Outcome Measures. 2007. http://www.fda.gov/cder/guidance/5460dft.htm. Accessed March 22, 2009.

10.1002/cncr.22893

10.1016/0304-3959(75)90044-5

Ekbom KA, 1945, Acta Med Scand, 158, 1

10.1002/mds.870100517

10.1093/sleep/23.5.1b

10.1159/000052098

10.1007/s00702-006-0614-3

10.1097/01.ajp.0000210948.11805.69

10.1016/j.pain.2008.04.025

10.1093/brain/awh441

10.1093/brain/awh079

10.1016/j.sleep.2010.11.007

10.1002/1531-8257(200003)15:2<289::AID-MDS1012>3.0.CO;2-E

10.1016/j.sleep.2008.10.006

10.1212/01.wnl.0000168910.48309.4a

10.1007/s11136-010-9677-6

10.1016/j.pedn.2005.03.011

10.1177/1367493508096204

10.1111/j.1365-263X.2010.01072.x

10.1016/j.yebeh.2004.12.005

10.1177/0883073807307985

10.1016/j.yebeh.2004.12.004

10.3109/02770900009090811

10.1111/j.1365-2214.1997.tb00889.x

10.1177/0883073809344122

10.2466/pms.1978.46.1.155

10.1542/peds.109.3.460

10.1177/08830738050200100501

10.1002/nur.4770180211

10.1542/peds.2007-1235

Thông tin
Thông tin xuất bản

Journal of Child Neurology

Tập 26 Số 11

1365-1376

Thông tin tác giả